Diplomat Pharmacy Inc (DPLO) Growth Rates Comparisons to Pharmacy Services & Retail Drugstore Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Diplomat Pharmacy Inc   (NYSE: DPLO)
 

Diplomat Pharmacy Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DPLO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -5.25 % 12.28 % 6.55 % 3.55 %
Q / Q Revenue Growth (Q3 MRQ) 1.05 % 3.84 % 5.49 % 4.37 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -1.53 % 9.76 % 6.26 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) -1.37 % 2.95 % 1.5 % 0.84 %
Revenue 5 Year Average Growth - 12.98 % 9.27 % 9.24 %


DPLO's Growth Comparisons in III. Quarter 2019




Although the Pharmacy Services & Retail Drugstore industry saw advancing Revenue by 12.28%, Diplomat Pharmacy Inc announced -5.25% year on year sales decline in the third quarter 2019, to $ 1.30 billions, and underperformed the 6.55% Revenue growth in the Retail sector. Although both Pharmacy Services & Retail Drugstore industry and Retail sector posted higher gains than 3.55% overall market increase, Diplomat Pharmacy Inc was trailing overall market in the third quarter.

Comparing the company's Revenue to the second quarter results, sales were higher by 1.05% . On the yearly basis, average annual sales growth for Diplomat Pharmacy Inc is %, while S & P 500's including only Businesses with the third quarter 2019 earnings, average annual sales growth is 9.24% over the past five years.


Growth Rates of DPLO's Income in the third quarter 2019


DPLO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - - 17.65 % -3.92 %
Sequential Operating Income Change (Q3 MRQ) - 28.63 % 8.01 % 31.33 %
Y / Y Operating Income Growth (Q3 TTM) - 44.18 % -11.8 % -12.37 %
Sequential Operating Income Growth (Q3 TTM) - 48.94 % 4.02 % -1.08 %
Operating Income 5 Year Avg. Change - -2.33 % 5.67 % 10.79 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - - 64.8 % -2.67 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) - 77.26 % 9.18 % 2.36 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 42.18 % 9.84 % 15.1 %
Sequential Income from Cont. Ops. Change (Q3 TTM) - 125.36 % 10.21 % -0.56 %
Income from Cont. Ops. 5 Year Avg. Change - -8.48 % 4.17 % 8.01 %

DPLO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - - 60.92 % -1.56 %
Q / Q Net Income Growth (Q3 MRQ) - 78.51 % 8.33 % -1.22 %
Y / Y Net Income Change (Q3 TTM) - 17.39 % 6.68 % 15.49 %
Sequential Net Income Change (Q3 TTM) - 113.77 % 9.65 % -0.81 %
Net Income 5 Year Avg. Growth - -3.86 % 4.78 % 8.3 %

DPLO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - - 64.8 % -2.67 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) - 132.5 % 9.18 % 2.36 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - 43.96 % - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) - 115.04 % -11.25 % 1.19 %
EPS from Cont. Ops. 5 Year Avg. Growth - -11.38 % 4.17 % 8.01 %



DPLO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - - 60.92 % -1.56 %
Q / Q EPS Net Growth (Q3 MRQ) - 134.14 % 8.33 % -1.22 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - 11.59 % 444.66 % 64.21 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) - 86.62 % -11.56 % 0.77 %
EPS Net 5 Year Avg. Change - -3.86 % 4.78 % 8.3 %



Diplomat Pharmacy Inc reported bottom-line of $ -2.35 in the third quarter, compare to $ 0.00 in the same quarter a year ago. Pharmacy Services & Retail Drugstore industry grew by 12.28%, while Retail sector increased by 60.92%, and overall market declined by -1.56%.

Comparing company's EPS to the second quarter results, income per share were higher by 1.05% . On the yearly basis, average annual income per share growth for Diplomat Pharmacy Inc is %, while S & P 500's including only the businesses with the third quarter 2019 Results, average annual income per share growth is 8.3% over the past five years.

DPLO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 62.49 % 2.31 % -5.2 %
Sequential Free Cash Flow Change (Q3 MRQ) -1.2 % 0.45 % 75.99 % 151.93 %
Y / Y Free Cash Flow Change (Q3 TTM) 58.78 % 14.34 % -3.97 % -2.89 %
Sequential Free Cash Flow Change (Q3 TTM) 666.42 % 12.11 % 0.98 % -0.64 %
Free Cash Flow 5 Year Avg. Change - 19.9 % 17.33 % 31.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) 334.89 % - - -
Sequential Net Cash Flow Change (Q3 MRQ) 22.49 % -81.66 % - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Sequential Net Cash Flow Change (Q3 TTM) - -38.44 % - -
Net Cash Flow 5 Year Avg. Change - - 18.99 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -15.08 % 20.64 % 42.22 % 8.09 %
Sequential Capital Expenditures Change (Q3 MRQ) -23.32 % -1.51 % -8.91 % 7.69 %
Y / Y Capital Expenditures Change (Q3 TTM) 14.46 % 12.66 % 3.96 % 5.78 %
Sequential Capital Expenditures Change (Q3 TTM) -3.33 % 4.59 % 1.32 % 0.75 %
Capital Expenditures 5 Year Avg. Change - 11.4 % 10.65 % 9.28 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.